Sempra (SRE) concluded trading on Wednesday at a closing price of $71.90, with 6.58 million shares of worth about $472.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.51% during that period and on March 05, 2025 the price saw a gain of about 1.80%. Currently the company’s common shares owned by public are about 651.46M shares, out of which, 650.98M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Stock saw a price change of -1.30% in past 5 days and over the past one month there was a price change of -12.94%. Year-to-date (YTD), SRE shares are showing a performance of -18.03% which increased to 2.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $64.89 but also hit the highest price of $95.77 during that period. The average intraday trading volume for Sempra shares is 4.87 million. The stock is currently trading -9.79% below its 20-day simple moving average (SMA20), while that difference is down -12.63% for SMA50 and it goes to -12.42% lower than SMA200.
Sempra (NYSE: SRE) currently have 651.46M outstanding shares and institutions hold larger chunk of about 91.41% of that.
The stock has a current market capitalization of $46.84B and its 3Y-monthly beta is at 0.68. PE ratio of stock for trailing 12 months is 16.27, while it has posted earnings per share of $4.42 in the same period. Its PEG reads 2.99 and has Quick Ratio of 0.49 while making debt-to-equity ratio of 1.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SRE, volatility over the week remained 2.87% while standing at 2.90% over the month.
Stock’s fiscal year EPS is expected to drop by -0.54% while it is estimated to increase by 9.39% in next year. EPS is likely to grow at an annualized rate of 5.44% for next 5-years, compared to annual growth of 3.92% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on March 03, 2025 offering a Hold rating for the stock and assigned a target price range of between $96 and $77 to it. Coverage by Barclays stated Sempra (SRE) stock as an Equal weight in their note to investors on February 27, 2025, suggesting a price target of $72 for the stock. On February 26, 2025, UBS Downgrade their recommendations, while on February 26, 2025, Goldman Downgrade their ratings for the stock with a price target of $76. Stock get an Overweight rating from Morgan Stanley on December 13, 2024.
